Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Overdiagnosis: When health services harm more than help

Charles Wright, MD
Physician
December 24, 2013
Share
Tweet
Share

“First, do no harm,” as suggested by Hippocrates, is a vital principle that should always guide physicians, but they are also well aware that in modern health care, whether in the form of drugs, operations, radiotherapy or any other form of treatment, there is always the possibility of causing harm to their patients.  All drugs have potential adverse side effects and all surgery carries risk.  Doctors and patients need to be reasonably satisfied that the likely balance of benefit and harm with any intervention is favorable.

Unfortunately, our ability now to test for and find insignificant abnormalities in people often leads to medical interventions that offer little or no benefit but still carry all the potential harms.  Harm as a consequence of necessary treatment can be accepted, but exposing healthy people to harm from treatment that they should not have had in the first place is unacceptable.

An international effort is now underway to identify the specifics of this “overdiagnosis” problem, to raise professional and public awareness about it, and to attempt to bring it under control.

Many features of our societal culture conspire to cause overdiagnosis and overtreatment, including the enormous public appetite for medical services, the erroneous notion that earlier diagnosis always causes a better result, the fear and denial of death, the huge advances in technology bringing an ever-widening range of sensitive diagnostic tests, and the inevitable vested interests of drug and technology firms and of health care professions.

The public are bombarded with messages on what disease they don’t know they have yet, what drug they should be taking, and what they must urgently talk to their doctor about.

There are abundant examples in current medical practice.  When enthusiastic specialty groups keep lowering the threshold level for calling a test for diabetes, kidney failure or high blood pressure abnormal, many more people are labeled with a disease.  Drug firm advertising has convinced the public that cholesterol is a disease rather than a normal component of the blood.  Normal human experiences, like grief, sadness, shyness, anxiety or hyperactivity risk getting you a diagnosis of a psychiatric “disorder” accompanied, of course, by a drug prescription.  The dangers of sleeping pills and of antibiotics for viral infections do not seem to be understood by huge numbers of patients — and, unfortunately, many physicians also.

Overdiagnosis is a serious problem in screening for cancer, especially of the prostate, breast and thyroid.  This has been a very hard lesson to learn in view of the high hopes and the resources that we have invested in screening programs as the way to reduce mortality from cancer.  The initial hope for the benefit of breast (mammography) and prostate (PSA) screening has been tempered by the more recent evidence on the very small size of the potential benefit in relation to the substantial harm caused by false positive tests.  For decades these screening tests have led to biopsies revealing microscopic cells that are currently labeled as “cancer” by the pathologist, but with uncertain potential to cause any significant problem for the patient in the future.

A biopsy report using the “c” word inevitably causes fear and distress for the patient and, frequently, an aggressive treatment plan from the doctors.  This problem — overdiagnosing cancer — is now widely recognized, even by the USA National Cancer Institute that recently issued a seminal report by an expert panel recommending that these uncertain “cancers” should instead be labeled “IDLE” (indolent lesions) until research can help us differentiate those that need treatment from those that do not.

Those working in the cancer field, including clinicians and pathologists will have to consider a new vocabulary, nomenclature and reporting language.  At the very least, physicians need to share honestly with patients the serious uncertainty about the prognosis for these so-called “cancers” rather than pretending that current treatments are always based on good evidence of benefit.

It is widely believed by health care analysts that a significant proportion of currently provided health services is inappropriate — whether due to overdiagnosis, overtreatment or unnecessary and repetitive testing and imaging.  This represents a huge wasted resource — health care dollars that could be spent productively elsewhere in the system — but even worse is the obvious fact that such services may not offer any benefit while subjecting patients to a wide range of all too familiar adverse side effects, risks and harms.

There is an urgent need for patients to be given more accurate and accessible information about the risks and benefits of health interventions, especially in screening programs involving normal healthy people with no signs or symptoms of disease.  And remember the old adage, in health care as in many other things: more is not always better.

Charles Wright is chair, Ontario Health Technology Advisory Committee. This article originally appeared in Evidence Network.

Prev

Could we exhale, my children and I?

December 24, 2013 Kevin 0
…
Next

Waking up from cardiac arrest

December 24, 2013 Kevin 1
…

ADVERTISEMENT

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Could we exhale, my children and I?
Next Post >
Waking up from cardiac arrest

ADVERTISEMENT

More by Charles Wright, MD

  • a desk with keyboard and ipad with the kevinmd logo

    The benefits of screening mammography have been greatly exaggerated

    Charles Wright, MD

More in Physician

  • a desk with keyboard and ipad with the kevinmd logo

    How to advance workforce development through research mentorship and evidence-based management

    Olumuyiwa Bamgbade, MD
  • The truth about perfection and identity in health care

    Ryan Nadelson, MD
  • Civil discourse as a leadership competency: the case for curiosity in medicine

    All Levels Leadership
  • When a medical office sublease turns into a legal nightmare

    Ralph Messo, DO
  • Why the heart of medicine is more than science

    Ryan Nadelson, MD
  • How Ukrainian doctors kept diabetes care alive during the war

    Dr. Daryna Bahriy
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician
    • Healing beyond the surface: Why proper chronic wound care matters

      Alvin May, MD | Conditions
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Overdiagnosis: When health services harm more than help
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...